Skip to main content
. 2024 Dec 19;16:981–991. doi: 10.2147/BCTT.S487988

Table 1.

Comparison of Clinicopathological Characteristics Between Training Set and Test Set

Characteristics Training Set (n=560) Test Set (n=140) P
Age (Year, Inline graphic) 48.96±10.41 48.67±9.56 0.251a
Menstrual status (%)
Premenopausal 254(45.4) 51(36.4) 0.057b
Postmenopausal 306(54.6) 89(63.6)
Location of disease (%)
Left breast 269(48.0) 72(51.4) 0.473b
Right breast 291(52.0) 68(48.6)
Tumor size [M (Q1, Q3)]mm 20(15,29) 22(16,27) 0.649c
HER2 status (%)
Negative 415(74.1) 101(72.1) 0.637b
Positive 145(25.9) 39(27.9)
ER status (%)
<10% 148(26.4) 41(29.3) 0.496b
≥10% 412(73.6) 99(70.7)
PR status (%)
≤20% 280(50.0) 75(53.6) 0.450b
>20% 280(50.0) 65(46.4)
Ki-67 (%)
≤20% 216(38.6) 58(41.4) 0.536b
>20% 344(61.4) 82(58.6)

Notes: aindependent-sample t-test; bchi-square test; cMann-Whitney U-test.